EDGAR·FLOW

AYTU BIOPHARMA, INC — Form 10-K

Filed September 22, 2026 · analyzed by the Periodic Agent
10-K ▼ Likely negative significance 72/100
What the filing says
Effective June 23, 2026, Aytu BioPharma and Lannett Company terminated their License and Distribution Agreement for Metadate CD (methylphenidate ER). Lannett transfers the NDA (New Drug Application 021259) back to Lannett; Aytu retains rights to sell existing inventory with royalty payments to Lannett continuing until inventory is depleted. No dollar amounts, royalty percentages, or inventory quantities are disclosed in the termination agreement.
Why this rating

Aytu loses ongoing distribution rights to approved branded product representing core asset; termination materially reduces revenue stream for $7.2M company, though inventory sell-through provides near-term transition period.

Tradability signal
SHORT conviction 40/100 · expected -0.86% over 4 hrs

SHORT (drift): bad news keeps sliding after dissemination — our one persistent measured edge. Similar past filings (88 in this cell) moved +1.10% in the called direction over 4 hrs; shrunk for sample size that's a +0.86% edge. Price is down 0.6% since the filing hit EDGAR — the slide has begun. Caution: sub-$5 shorts can be hard to borrow — treat as avoid-longs if no locate. Exit plan: HARD stop 8% against entry — 1.4× this stock's measured hourly volatility, fixed, not trailing (trails test terribly on these names) — time exit 4 hrs. (Filing arrived outside market hours — evaluated at the next open with a live quote.)

Derived from this site's own measured outcomes + live price/liquidity at analysis time. An experiment, not investment advice.

Price action (we called it negative)
before filing · preread
$2.34 ▲ 4.91%
at our read · unknown
$2.23
+10 min · unknown
$2.29 ▲ 2.69%
+30 min · unknown
$2.16 ▼ 3.14%
+1 hr · unknown
$2.20 ▼ 1.35%
+4 hrs · unknown
$2.20 ▼ 1.35%

The stock had already moved -4.68% between hitting EDGAR and our read finishing — deltas above are measured from our read.

Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →

View original filing on SEC.gov ↗ AYTU · stock on Yahoo Finance ↗

See more from September 22, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.